The search result for the key word "PUDTI"

A total of 12 results found based on your keywords
Recommendation ID Data Information Model Information Application Information Reference
Rank Total_Score Model_ID Dataset_Name Element_type Data_features Model_name Algorithm_name Prediction_type Code_source Study_types Disease_name Target_name Drug_name Interaction_type Recommended_Number PMID Journal Publication_Year
1 66.2 386 Yamanishi_GPCR Drug, Target Drug: molecule, Target: target sequence PUDTI Support Vector Machine (SVM) Drug Target Interaction (DTI) NA Case studies Alzheimer's Disease (AD) (D(1A), D(2) and D3 dopamine receptors (P21728, P14416 and P35462), alpha-1A and alpha-1B adrenergic receptor (P35348 and P35368), 5-hydroxytryptamine receptors (P28223) and potassium voltage-gated channel subfamily H member 2(Q12809) NA NA NA 28808275 Sci Rep 2017
1 66.2 386 Yamanishi_IC Drug, Target Drug: molecule, Target: target sequence PUDTI Support Vector Machine (SVM) Drug Target Interaction (DTI) NA Case studies NA DNA topoisomerase 2-alpha (P11388) NA NA 31 drugs 28808275 Sci Rep 2017
1 66.2 386 Yamanishi_E Drug, Target Drug: molecule, Target: target sequence PUDTI Support Vector Machine (SVM) Drug Target Interaction (DTI) NA Case studies NA NA Astemizole NA 14 targets 28808275 Sci Rep 2017
1 66.2 386 Yamanishi_NR Drug, Target Drug: molecule, Target: target sequence PUDTI Support Vector Machine (SVM) Drug Target Interaction (DTI) NA Case studies NA NA Astemizole NA 14 targets 28808275 Sci Rep 2017
1 66.2 386 Yamanishi_IC Drug, Target Drug: molecule, Target: target sequence PUDTI Support Vector Machine (SVM) Drug Target Interaction (DTI) NA Case studies Alzheimer's Disease (AD) (D(1A), D(2) and D3 dopamine receptors (P21728, P14416 and P35462), alpha-1A and alpha-1B adrenergic receptor (P35348 and P35368), 5-hydroxytryptamine receptors (P28223) and potassium voltage-gated channel subfamily H member 2(Q12809) NA NA NA 28808275 Sci Rep 2017
1 66.2 386 Yamanishi_E Drug, Target Drug: molecule, Target: target sequence PUDTI Support Vector Machine (SVM) Drug Target Interaction (DTI) NA Case studies NA DNA topoisomerase 2-alpha (P11388) NA NA 31 drugs 28808275 Sci Rep 2017
1 66.2 386 Yamanishi_NR Drug, Target Drug: molecule, Target: target sequence PUDTI Support Vector Machine (SVM) Drug Target Interaction (DTI) NA Case studies NA DNA topoisomerase 2-alpha (P11388) NA NA 31 drugs 28808275 Sci Rep 2017
1 66.2 386 Yamanishi_GPCR Drug, Target Drug: molecule, Target: target sequence PUDTI Support Vector Machine (SVM) Drug Target Interaction (DTI) NA Case studies NA NA Astemizole NA 14 targets 28808275 Sci Rep 2017
1 66.2 386 Yamanishi_E Drug, Target Drug: molecule, Target: target sequence PUDTI Support Vector Machine (SVM) Drug Target Interaction (DTI) NA Case studies Alzheimer's Disease (AD) (D(1A), D(2) and D3 dopamine receptors (P21728, P14416 and P35462), alpha-1A and alpha-1B adrenergic receptor (P35348 and P35368), 5-hydroxytryptamine receptors (P28223) and potassium voltage-gated channel subfamily H member 2(Q12809) NA NA NA 28808275 Sci Rep 2017
1 66.2 386 Yamanishi_IC Drug, Target Drug: molecule, Target: target sequence PUDTI Support Vector Machine (SVM) Drug Target Interaction (DTI) NA Case studies NA NA Astemizole NA 14 targets 28808275 Sci Rep 2017
1 66.2 386 Yamanishi_NR Drug, Target Drug: molecule, Target: target sequence PUDTI Support Vector Machine (SVM) Drug Target Interaction (DTI) NA Case studies Alzheimer's Disease (AD) (D(1A), D(2) and D3 dopamine receptors (P21728, P14416 and P35462), alpha-1A and alpha-1B adrenergic receptor (P35348 and P35368), 5-hydroxytryptamine receptors (P28223) and potassium voltage-gated channel subfamily H member 2(Q12809) NA NA NA 28808275 Sci Rep 2017
1 66.2 386 Yamanishi_GPCR Drug, Target Drug: molecule, Target: target sequence PUDTI Support Vector Machine (SVM) Drug Target Interaction (DTI) NA Case studies NA DNA topoisomerase 2-alpha (P11388) NA NA 31 drugs 28808275 Sci Rep 2017
logo
All rights reserved: Institutes for Systems Genetics, West China Hospital